For updated information about JADPRO Live 2020, please visit JADPROLive.com

 
Section Seperator

TODAY'S NEWS

New Report Focuses on Cancer Statistics ...

A new report examining cancer in adolescents and y...

Surgery With or Without Preoperative Rad...

As reported in The Lancet Oncology by Bonvalot et ...

Impact of Neoadjuvant Endocrine Therapy ...

“Studies that have compared neoadjuvant endocrine ...

First-Line Checkpoint Inhibitors May Imp...

Immune therapy for advanced gastroesophageal cance...

Impact of Prior Insurance Coverage Disru...

A new study from the American Cancer Society has f...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

https://www.advancedpractitioner.com/issues/volume-11,-number-6-(aug-2020)/asco20-virtual-scientific-program-takeaways-for-the-advanced-practitioner.aspx

CAR T-cell therapy is rapidly emerging as a promising treatment for many hematologic malignancies...

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights More Highlights
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
 
 
Designed by Harborside
Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.